-
Rituximab went off patent in the US last year, leaving it open to competition
Celltrion and Teva look set to get a biosimilar of Roche’s blockbuster MabThera/Rituxan (rituximab) onto the US market ahead of rivals.
Rituximab went off patent in the US last year, leaving it open to competition from cheaper biosimilar versions.
It is Roche’s biggest selling drug, generating around $7.3 billion in sales in 2016, and more than $3.9 billion of this revenue was based in the US.
It is used in non-Hodgkin’s lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis ......
Read more here: https://pharmaphorum.com/news/celltr...biosimilar-us/
-
Post Thanks / Like - 6 Likes
-
FDA Will Review Application Seeking Approval of Truxima for Same Indications as Rituxan
https://lymphomanewstoday.com/2017/0...milar-rituxan/
-
Post Thanks / Like - 2 Likes
-
If approved, it might be a more affordable option for a lot of folks!!!
Nice find!
MikeG-2012
"You never know how strong you are until being strong is the only choice you have"
-
Post Thanks / Like - 4 Likes
-
Wow this is great news if it gets approved
-
Post Thanks / Like - 2 Likes
-
Originally Posted by
Bing505z
Celltrion and Teva look set to get a biosimilar of Roche’s blockbuster MabThera/Rituxan (rituximab) onto the US market ahead of rivals.
Rituximab went off patent in the US last year, leaving it open to competition from cheaper biosimilar versions.
It is Roche’s biggest selling drug, generating around $7.3 billion in sales in 2016, and more than $3.9 billion of this revenue was based in the US.
It is used in non-Hodgkin’s lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis ......
Read more here: https://pharmaphorum.com/news/celltr...biosimilar-us/
Thanks for sharing. Wonderful picture with your beautiful baby and wife.
My fear is that the health service will prescribe the generic med which will not be as good as the original. I saw it with few meds when the generic is bad version.
-
Post Thanks / Like - 2 Likes
-
Originally Posted by
MikeG-2012
If approved, it might be a more affordable option for a lot of folks!!!
Nice find!
Lets hope so!
-
Post Thanks / Like - 1 Likes
Jaha liked this post
-
Originally Posted by
Alysia
Thanks for sharing. Wonderful picture with your beautiful baby and wife.
My fear is that the health service will prescribe the generic med which will not be as good as the original. I saw it with few meds when the generic is bad version.
Ty for your kind words. Hope this option works just as good as the original!
-
Post Thanks / Like - 1 Likes
Jaha liked this post
-
This is big news! I do understand the need for pharms to get back the money they have invested in research, but sometimes the costs are just astronomical.
Several weeks ago I mentioned that I have been dx'ed as hypopara. The typical treatment is calcitirol and calcium tabs which is very cheap, but I'm now trying a pth replacement called natpara. It costs about $800 per daily injection. I don't know if I can justify staying on it.
-
Originally Posted by
vdub
It costs about $800 per daily injection. I don't know if I can justify staying on it.
OUCH!!
Hope your insurance is covering it!
MikeG-2012
"You never know how strong you are until being strong is the only choice you have"
-
Post Thanks / Like - 1 Likes
Jaha liked this post
-
Hope your insurance is covering it!
It does, but it is an awfully unfair expense for the taxpayers. Unless it works wonders, I won't continue it.
-
Post Thanks / Like - 1 Likes
Jaha liked this post
Bookmarks